Abingdon Health Plc (ABDXF) Q2 2026 Earnings Call Transcript

Operator

Good morning, ladies and gentlemen, and welcome to the Abingdon Health plc Half Year Results Investor Presentation. [Operator Instructions] The company may not be in a position to answer every question it receives during the meeting itself. However, the company can review all questions submitted today and we’ll publish our responses where it’s appropriate to do so on the Investor Meet company platform. Before we begin, we would like to submit the following poll. And if you’d give that your kind attention, I’m sure the company would be most grateful.

And I would now like to hand you over to Executive Chairman, Chris Hand. Chris, good morning, sir.

Christopher Hand
Executive Chairman

Good morning, and good morning, everyone. Thank you for joining this half year results presentation of Abingdon Health. These are the results to the 31st of December ’25. So I’m Chris Hand. I’m one of the founders of Abingdon Health and Executive Chairman, a role I took up about a year ago to allow my Co-Founder, Chris Yates, to focus on our global commercial activities and our U.S.A. expansion.

My background is in medical diagnostics, 30 years plus in medical diagnostics and specifically rapid testing, which I did both within Abingdon and previously at a company called Cozart, where we specialized in drugs abuse testing using lateral flow.

I’m joined today by my colleague, Tom Hayes, who’s CFO.

Thomas Hayes
Secretary, CFO & Director

Thanks, Chris. So good morning, everyone. So I’m Tom Hayes. I joined Abingdon Health just over 12 months ago now as Chief Financial Officer. Previously, I was Group Finance Director for